154 related articles for article (PubMed ID: 30953293)
1. Factors associated with low health-related quality of life among younger and older Thai patients with non-valvular atrial fibrillation.
Srinonprasert V; Ratanasumawong K; Thongsri T; Dutsadeevettakul S; Jittham P; Wiwatworapan W; Krittayaphong R;
Qual Life Res; 2019 Aug; 28(8):2091-2098. PubMed ID: 30953293
[TBL] [Abstract][Full Text] [Related]
2. Age-Related Clinical Outcomes of Patients with Non-Valvular Atrial Fibrillation: Insights from the COOL-AF Registry.
Krittayaphong R; Boonyapiphat T; Wongvipaporn C; Sairat P;
Clin Interv Aging; 2021; 16():707-719. PubMed ID: 33953549
[TBL] [Abstract][Full Text] [Related]
3. Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study.
Biteker M; Başaran Ö; Doğan V; Altun İ; Özpamuk Karadeniz F; Tekkesin Aİ; Çakıllı Y; Türkkan C; Hamidi M; Demir V; Gürsoy MO; Tek Öztürk M; Aksan G; Seyis S; Ballı M; Alıcı MH; Bozyel S
J Am Geriatr Soc; 2017 Aug; 65(8):1684-1690. PubMed ID: 28394435
[TBL] [Abstract][Full Text] [Related]
4. Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study.
Ng DL; Malik NMBA; Chai CS; Goh GM; Tan SB; Bee PC; Gan GG; Said AB
Health Qual Life Outcomes; 2020 Oct; 18(1):347. PubMed ID: 33081816
[TBL] [Abstract][Full Text] [Related]
5. Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation - SAMURAI-NVAF Study.
Yoshimura S; Koga M; Sato S; Todo K; Yamagami H; Kumamoto M; Itabashi R; Terasaki T; Kimura K; Yagita Y; Shiokawa Y; Kamiyama K; Okuda S; Okada Y; Takizawa S; Hasegawa Y; Kameda T; Shibuya S; Nagakane Y; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Fujita K; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yamaguchi Y; Kinoshita N; Matsuki T; Takasugi J; Tokunaga K; Higashida K; Homma K; Kario K; Arihiro S; Toyoda K;
Circ J; 2018 Jun; 82(7):1935-1942. PubMed ID: 29863095
[TBL] [Abstract][Full Text] [Related]
6. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study.
Krittayaphong R; Winijkul A; Methavigul K; Wongtheptien W; Wongvipaporn C; Wisaratapong T; Kunjara-Na-Ayudhya R; Boonyaratvej S; Komoltri C; Kaewcomdee P; Yindeengam A; Sritara P;
BMC Cardiovasc Disord; 2018 Aug; 18(1):174. PubMed ID: 30144802
[TBL] [Abstract][Full Text] [Related]
7. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
8. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
[TBL] [Abstract][Full Text] [Related]
9. Impact of anemia on clinical outcomes of patients with atrial fibrillation: The COOL-AF registry.
Krittayaphong R; Pumprueg S; Thongsri T; Wiwatworapan W; Choochunklin T; Kaewkumdee P; Yindeengam A;
Clin Cardiol; 2021 Mar; 44(3):415-423. PubMed ID: 33538035
[TBL] [Abstract][Full Text] [Related]
10. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
[TBL] [Abstract][Full Text] [Related]
11. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
[No Abstract] [Full Text] [Related]
12. SAMe-TT2R2 score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation.
Krittayaphong R; Winijkul A; Pirapatdit A; Chiewvit P; Komoltri C; Boonyapisit W; Arunsiriwattana S; Bunyapipat T; Apiyasawat S; Rattanasumawong K; Yindeengam A;
Singapore Med J; 2020 Dec; 61(12):641-646. PubMed ID: 31680175
[TBL] [Abstract][Full Text] [Related]
13. Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trials.
Deitelzweig S; Amin A; Jing Y; Makenbaeva D; Wiederkehr D; Lin J; Graham J
J Med Econ; 2013 Sep; 16(9):1163-8. PubMed ID: 23869941
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life, anxiety and depression up to 12 months post-stroke: Influence of sex, age, stroke severity and atrial fibrillation - A longitudinal subanalysis of the Find-AF
Sadlonova M; Wasser K; Nagel J; Weber-Krüger M; Gröschel S; Uphaus T; Liman J; Hamann GF; Kermer P; Gröschel K; Herrmann-Lingen C; Wachter R
J Psychosom Res; 2021 Mar; 142():110353. PubMed ID: 33421630
[TBL] [Abstract][Full Text] [Related]
15. Real world adherence to oral anticoagulant in non-valvular atrial fibrillation patients in China.
Xiang X; Cao Y; Sun K; Song J; Tian Y; Yin Q; Juan J; Hu Y
Curr Med Res Opin; 2018 Feb; 34(2):255-261. PubMed ID: 29022745
[TBL] [Abstract][Full Text] [Related]
16. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
[TBL] [Abstract][Full Text] [Related]
17. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
18. Use of warfarin in elderly patients with non-valvular atrial fibrillation -- subanalysis of the J-RHYTHM Registry.
Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
Circ J; 2015; 79(11):2345-52. PubMed ID: 26329097
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
Gullón A; Suárez C; Díez-Manglano J; Formiga F; Cepeda JM; Pose A; Camafort M; Castiella J; Rovira E; Mostaza JM;
Med Clin (Barc); 2017 Mar; 148(5):204-210. PubMed ID: 27993408
[TBL] [Abstract][Full Text] [Related]
20. Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective study.
Cullinane M; Wainwright R; Brown A; Monaghan M; Markus HS
Stroke; 1998 Sep; 29(9):1810-5. PubMed ID: 9731600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
